DIGITALIFT Inc. Logo

DIGITALIFT Inc.

Digital marketing firm providing programmatic ad operations and strategic consulting services.

9244 | T

Overview

Corporate Details

ISIN(s):
JP3548950009
LEI:
Country:
Japan
Address:
渋谷区神宮前六丁目17番11号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

DIGITALIFT Inc. is a digital marketing company that optimizes user experiences through digital technology. The company's core operations are centered on two main pillars: a trading desk business and a consulting business. Its trading desk provides 'Agile Advertising Operation' services, offering end-to-end management of programmatic advertising from campaign design and ad delivery to reporting and analysis. The consulting division delivers strategic support, including a Chief Digital Marketing Officer (CdMO) service that helps clients solve high-level management challenges from a marketing perspective. Additional offerings include SEO consulting, creative production for social media, and 'LIFT+', a specialized service for clients with smaller budgets in their initial growth phase. The company aims to maximize value for both its clients and their end-users through precisely timed and targeted information delivery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-14 05:10
Registration Form
確認書
Japanese 8.7 KB
2025-05-14 05:09
Interim Report
半期報告書-第13期(2024/10/01-2025/09/30)
Japanese 255.8 KB
2025-01-31 09:11
M&A Activity
臨時報告書
Japanese 34.0 KB
2024-12-23 03:04
Post-Annual General Meeting Information
臨時報告書
Japanese 23.6 KB
2024-12-20 08:22
Regulatory News Service
確認書
Japanese 8.7 KB
2024-12-20 08:22
Regulatory News Service
内部統制報告書-第12期(2023/10/01-2024/09/30)
Japanese 23.4 KB
2024-12-20 08:21
Annual Report
有価証券報告書-第12期(2023/10/01-2024/09/30)
Japanese 1.3 MB
2024-11-21 04:08
Regulatory News Service
臨時報告書
Japanese 21.5 KB
2024-11-14 08:05
Regulatory News Service
臨時報告書
Japanese 22.3 KB
2024-05-14 08:06
Report Publication Announcement
確認書
Japanese 9.0 KB
2024-05-14 08:06
Quarterly Report
四半期報告書-第12期第2四半期(2024/01/01-2024/03/31)
Japanese 186.8 KB
2024-02-14 07:29
Report Publication Announcement
確認書
Japanese 8.9 KB
2024-02-14 07:29
Quarterly Report
四半期報告書-第12期第1四半期(2023/10/01-2023/12/31)
Japanese 145.6 KB
2023-12-25 02:37
Post-Annual General Meeting Information
臨時報告書
Japanese 22.1 KB
2023-12-22 04:02
Governance Information
内部統制報告書-第11期(2022/10/01-2023/09/30)
Japanese 23.5 KB

Automate Your Workflow. Get a real-time feed of all DIGITALIFT Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DIGITALIFT Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DIGITALIFT Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.